# Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

> **NCT00601614** · PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** temozolomide
- **DRUG:** vandetanib
- **OTHER:** immunoenzyme technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00601614
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no enrollment
- **Last updated:** 2014-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601614, "Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00601614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*